Neil Kumar's most recent trade in BridgeBio Pharma Inc was a trade of 8,721 Common Stock done at an average price of $69.0 . Disclosure was reported to the exchange on Sept. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.01 per share. | 17 Sep 2026 | 8,721 | 496,965 (0%) | 0% | 69.0 | 601,868 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.57 per share. | 17 Sep 2026 | 1,279 | 495,686 (0%) | 0% | 69.6 | 88,980 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.21 per share. | 18 Aug 2026 | 17,279 | 259,128 (0%) | 0% | 82.2 | 1,420,514 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.99 per share. | 18 Aug 2026 | 14,602 | 244,526 (0%) | 0% | 83.0 | 1,211,852 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 83.86 per share. | 18 Aug 2026 | 8,100 | 507,586 (0%) | 0% | 83.9 | 679,256 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 81.15 per share. | 18 Aug 2026 | 1,900 | 276,407 (0%) | 0% | 81.1 | 154,184 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 84.69 per share. | 18 Aug 2026 | 1,800 | 505,786 (0%) | 0% | 84.7 | 152,436 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 83.77 per share. | 18 Aug 2026 | 1,199 | 243,327 (0%) | 0% | 83.8 | 100,444 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 85.65 per share. | 18 Aug 2026 | 100 | 505,686 (0%) | 0% | 85.7 | 8,565 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.86 per share. | 16 Aug 2026 | 36,237 | 278,307 (0%) | 0% | 79.9 | 2,893,887 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2026 | 33,544 | 276,871 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 Aug 2026 | 33,544 | 67,088 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 Aug 2026 | 19,599 | 117,596 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2026 | 19,599 | 296,470 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 Aug 2026 | 11,554 | 115,538 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2026 | 11,554 | 308,024 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 Aug 2026 | 6,520 | 91,274 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2026 | 6,520 | 314,544 (0%) | 0% | - | Common Stock | |
| BridgeBio Oncology Therapeutics Inc | Dr. Neil Kumar, PhD | Director | 16 Jun 2026 | 31,675 | 31,675 | - | - | Stock Option (Right to Buy) | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.74 per share. | 04 Jun 2026 | 15,921 | 4,338,897 (3%) | 0% | 67.7 | 1,078,452 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.74 per share. | 04 Jun 2026 | 15,921 | 536,136 (0%) | 0% | 67.7 | 1,078,454 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.88 per share. | 04 Jun 2026 | 8,437 | 4,322,862 (3%) | 0% | 67.9 | 572,744 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.88 per share. | 04 Jun 2026 | 8,437 | 520,102 (0%) | 0% | 67.9 | 572,744 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.20 per share. | 04 Jun 2026 | 7,148 | 4,331,299 (3%) | 0% | 67.2 | 480,338 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.20 per share. | 04 Jun 2026 | 7,147 | 528,539 (0%) | 0% | 67.2 | 480,271 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.96 per share. | 04 Jun 2026 | 4,416 | 515,686 (0%) | 0% | 69.0 | 304,524 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.96 per share. | 04 Jun 2026 | 4,415 | 4,318,447 (3%) | 0% | 69.0 | 304,455 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.72 per share. | 04 Jun 2026 | 2,200 | 553,486 (0%) | 0% | 65.7 | 144,584 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.72 per share. | 04 Jun 2026 | 2,200 | 4,356,247 (3%) | 0% | 65.7 | 144,584 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.72 per share. | 04 Jun 2026 | 1,429 | 4,354,818 (3%) | 0% | 66.7 | 95,347 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.72 per share. | 04 Jun 2026 | 1,429 | 552,057 (0%) | 0% | 66.7 | 95,347 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.27 per share. | 04 Jun 2026 | 450 | 4,338,447 (3%) | 0% | 68.3 | 30,721 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.27 per share. | 04 Jun 2026 | 450 | 535,686 (0%) | 0% | 68.3 | 30,721 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.48 per share. | 21 May 2026 | 11,250 | 244,127 (0%) | 0% | 70.5 | 792,916 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.30 per share. | 21 May 2026 | 6,725 | 260,449 (0%) | 0% | 68.3 | 459,334 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.22 per share. | 21 May 2026 | 5,072 | 255,377 (0%) | 0% | 69.2 | 351,102 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.57 per share. | 21 May 2026 | 2,256 | 267,174 (0%) | 0% | 67.6 | 152,435 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.92 per share. | 21 May 2026 | 800 | 243,327 (0%) | 0% | 70.9 | 56,735 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.13 per share. | 16 May 2026 | 36,236 | 269,430 (0%) | 0% | 66.1 | 2,396,287 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2026 | 33,544 | 267,995 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 May 2026 | 33,544 | 100,632 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2026 | 19,599 | 287,594 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 May 2026 | 19,599 | 137,195 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2026 | 11,553 | 299,147 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 May 2026 | 11,553 | 127,092 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2026 | 6,519 | 305,666 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 May 2026 | 6,519 | 97,794 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.65 per share. | 07 May 2026 | 13,974 | 4,364,473 (3%) | 0% | 66.7 | 931,374 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.65 per share. | 07 May 2026 | 13,973 | 561,713 (0%) | 0% | 66.7 | 931,307 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.49 per share. | 07 May 2026 | 11,217 | 584,469 (0%) | 0% | 67.5 | 757,091 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.49 per share. | 07 May 2026 | 11,217 | 4,387,230 (3%) | 0% | 67.5 | 757,090 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.38 per share. | 07 May 2026 | 8,334 | 4,378,896 (3%) | 0% | 68.4 | 569,858 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.38 per share. | 07 May 2026 | 8,333 | 576,136 (0%) | 0% | 68.4 | 569,790 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.35 per share. | 07 May 2026 | 5,077 | 556,636 (0%) | 0% | 67.3 | 341,913 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.35 per share. | 07 May 2026 | 5,076 | 4,359,397 (3%) | 0% | 67.3 | 341,846 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.35 per share. | 07 May 2026 | 950 | 4,358,447 (3%) | 0% | 68.3 | 64,930 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.35 per share. | 07 May 2026 | 950 | 555,686 (0%) | 0% | 68.3 | 64,930 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.09 per share. | 07 May 2026 | 450 | 575,686 (0%) | 0% | 69.1 | 31,091 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.09 per share. | 07 May 2026 | 449 | 4,378,447 (3%) | 0% | 69.1 | 31,022 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 20,000 | 595,686 (0%) | 0% | 74.6 | 1,492,096 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 20,000 | 4,398,447 (3%) | 0% | 74.6 | 1,492,076 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.53 per share. | 09 Apr 2026 | 7,800 | 4,418,447 (3%) | 0% | 75.5 | 589,124 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.55 per share. | 09 Apr 2026 | 7,500 | 615,686 (0%) | 0% | 75.6 | 566,661 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 09 Apr 2026 | 7,200 | 628,486 (0%) | 0% | 73.6 | 530,240 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 09 Apr 2026 | 7,072 | 4,431,375 (3%) | 0% | 73.6 | 520,801 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 09 Apr 2026 | 5,300 | 623,186 (0%) | 0% | 74.6 | 395,403 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.57 per share. | 09 Apr 2026 | 5,128 | 4,426,247 (3%) | 0% | 74.6 | 382,379 | Common Stock |
| Maze Therapeutics Inc | Dr. Neil Kumar, PhD | Director | 27 Mar 2026 | 33,417 | 33,417 | - | - | Stock Option (Right to Buy) | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 17 Mar 2026 | 104,313 | 104,313 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 17 Mar 2026 | 40,570 | 40,570 | - | - | Stock Option (Right to Buy) | ||
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.48 per share. | 12 Mar 2026 | 14,337 | 661,349 (0%) | 0% | 68.5 | 981,809 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.48 per share. | 12 Mar 2026 | 14,337 | 661,349 (0%) | 0% | 68.5 | 981,809 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.47 per share. | 12 Mar 2026 | 13,885 | 4,464,562 (3%) | 0% | 68.5 | 950,687 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.47 per share. | 12 Mar 2026 | 13,885 | 4,464,562 (3%) | 0% | 68.5 | 950,687 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.20 per share. | 12 Mar 2026 | 10,310 | 635,686 (0%) | 0% | 69.2 | 713,449 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.20 per share. | 12 Mar 2026 | 10,310 | 635,686 (0%) | 0% | 69.2 | 713,449 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.39 per share. | 12 Mar 2026 | 10,241 | 4,448,206 (3%) | 0% | 68.4 | 700,345 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.39 per share. | 12 Mar 2026 | 10,241 | 4,448,206 (3%) | 0% | 68.4 | 700,345 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.23 per share. | 12 Mar 2026 | 9,759 | 4,438,447 (3%) | 0% | 69.2 | 675,568 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.23 per share. | 12 Mar 2026 | 9,759 | 4,438,447 (3%) | 0% | 69.2 | 675,568 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.36 per share. | 12 Mar 2026 | 9,690 | 645,996 (0%) | 0% | 68.4 | 662,441 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.36 per share. | 12 Mar 2026 | 9,690 | 645,996 (0%) | 0% | 68.4 | 662,441 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.29 per share. | 12 Mar 2026 | 5,815 | 4,458,747 (3%) | 0% | 69.3 | 402,929 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.29 per share. | 12 Mar 2026 | 5,815 | 4,458,747 (3%) | 0% | 69.3 | 402,929 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.32 per share. | 12 Mar 2026 | 5,363 | 655,986 (0%) | 0% | 69.3 | 371,750 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.32 per share. | 12 Mar 2026 | 5,363 | 655,986 (0%) | 0% | 69.3 | 371,750 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.15 per share. | 12 Mar 2026 | 300 | 4,458,447 (3%) | 0% | 70.2 | 21,045 | Common Stock |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.15 per share. | 12 Mar 2026 | 300 | 655,686 (0%) | 0% | 70.2 | 21,045 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.15 per share. | 12 Mar 2026 | 300 | 655,686 (0%) | 0% | 70.2 | 21,045 | - |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.15 per share. | 12 Mar 2026 | 300 | 4,458,447 (3%) | 0% | 70.2 | 21,045 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.03 per share. | 19 Feb 2026 | 18,923 | 243,581 (0%) | 0% | 71.0 | 1,344,190 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.03 per share. | 19 Feb 2026 | 18,923 | 243,581 (0%) | 0% | 71.0 | 1,344,190 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.08 per share. | 19 Feb 2026 | 8,528 | 235,053 (0%) | 0% | 72.1 | 614,702 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.08 per share. | 19 Feb 2026 | 8,528 | 235,053 (0%) | 0% | 72.1 | 614,702 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.80 per share. | 19 Feb 2026 | 602 | 234,451 (0%) | 0% | 72.8 | 43,826 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 72.80 per share. | 19 Feb 2026 | 602 | 234,451 (0%) | 0% | 72.8 | 43,826 | - |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 33,544 | 262,320 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | 16 Feb 2026 | 33,544 | 134,176 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2026 | 33,544 | 262,320 (0%) | 0% | - | - | |
| BridgeBio Pharma Inc | Dr. Neil Kumar, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 16 Feb 2026 | 30,970 | 262,504 (0%) | 0% | 75.3 | 2,330,493 | Common Stock |
| BridgeBio Pharma Inc | Mr. Neil Kumar, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 16 Feb 2026 | 30,970 | 262,504 (0%) | 0% | 75.3 | 2,330,493 | - |